CARLSMED, INC. (CARL)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, CARLSMED, INC. reported revenue of $50.51M, up 85.9% from the prior year. The company ran a net loss, with a net margin of -58.7% and a gross margin of 75.3%. It held $130.12M in total assets against $31.25M in total liabilities.
Key ratios (FY2025)
75.3%
Gross margin
-60.5%
Operating margin
-58.7%
Net margin
-30.0%
Return on equity
+85.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $50.51M | $27.16M | — |
| Cost of Revenue | $12.47M | $7.12M | — |
| Gross Profit | $38.04M | $20.05M | — |
| Operating Income | -$30.57M | -$24.12M | — |
| Net Income | -$29.63M | -$24.26M | — |
| EPS (Diluted) | $-2.12 | $-6.11 | — |
| Total Assets | $130.12M | $51.82M | — |
| Total Liabilities | $31.25M | $26.23M | — |
| Shareholders' Equity | $98.87M | -$70.63M | -$46.13M |
| Cash & Equivalents | $85.79M | $40.12M | $7.22M |
| Operating Cash Flow | -$28.98M | -$25.47M | — |
| Capital Expenditures | $642.0K | $180.0K | — |
| Shares Outstanding | 26.60M | 4.14M | — |